Logo-bi
Bioimpacts. 2019;9(4): 211-217. doi: 10.15171/bi.2019.26
PMID: 31799157        PMCID: PMC6879712

Original Research

Mode of photoexcited C60 fullerene involvement in potentiating cisplatin toxicity against drug-resistant L1210 cells

Daria Franskevych 1 ORCID, Svitlana Prylutska 1 * ORCID, Iryna Grynyuk 1 ORCID, Ganna Pasichnyk 2 ORCID, Liudmyla Drobot 2 ORCID, Olga Matyshevska 1,2 ORCID, Uwe Ritter 3 ORCID

Cited by CrossRef: 3

1- Cheng Z, Li M, Dey R, Chen Y. Nanomaterials for cancer therapy: current progress and perspectives. J Hematol Oncol. 2021;14(1) [Crossref]
2- Szupryczyński K, Czeleń P, Jeliński T, Szefler B. What is the Reason That the Pharmacological Future of Chemotherapeutics in the Treatment of Lung Cancer Could Be Most Closely Related to Nanostructures? Platinum Drugs in Therapy of Non-Small and Small Cell Lung Cancer and Their Unexpected, Possible Interactions. The Review. IJN. 2024;Volume 19:9503 [Crossref]
3- Mirzaei S, Hushmandi K, Zabolian A, Saleki H, Torabi S, Ranjbar A, SeyedSaleh S, Sharifzadeh S, Khan H, Ashrafizadeh M, Zarrabi A, Ahn K. Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic Strategies. Molecules. 2021;26(8):2382 [Crossref]

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge